Medomics Novel Virus & Flu a/B Combined Antigen Medical Test Kit
Contact Supplier
Still deciding? Get samples of $ !
Request Sample
Product Highlights
- High Sensitivity and Specificity: Sensitivity exceeds 95% with 100% specificity for accurate detection.
- Rapid 10-Minute Results: Delivers qualitative detection results in just 10 minutes.
- Triple Virus Detection: Simultaneously detects Influenza A, Influenza B, and Novel Virus antigens.
- ISO and CE Certified: Product holds ISO and CE certifications for quality assurance.
- Flexible Customization Options: Offers full, minor, and sample-based customization services.
- GMP Compliant Production: Manufactured in a 10,000 sqm GMP purification workshop.
- Global R&D Expertise: Supported by R&D centers in China and the US with 50% technical staff.
- Stable Storage Conditions: Maintains stability at temperatures between 4-30 degrees Celsius.
Product Attributes
- Customization
- Available
- Type
- IVD Reagent
- Certificate
- ISO, CE
- Model NO.
- Antigen Test
- Transport Package
- Box+Carton
- Trademark
- OBM/OEM
- Origin
- China
- HS Code
- 3002150090
- Production Capacity
- 5, 000, 000 Pieces/Month
Product Images of Medomics Novel Virus & Flu a/B Combined Antigen Medical Test Kit
Find Similar Products
Product Description
Medomics Flu A&B and Novel Virus Antigen Test Kit (LFIA) is used to qualitatively detect influenza virus type A, influenza virus typeB and novel virus antigens in human samples in vitro. 2019 Novel Virus belongs to the order Nidovirales under the Coronaviridae family with 4 genera: α, β, γ and δ. The α and β genera are only pathogenic to mammals, while γ and δ genera mainly causes bird infections.
Since Flu A&B and 2019 novel virus have similar symptoms and routes of infection, the kit has important clinical significance in identifying them.